mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. - Wikidata - awgldk - TriplyDB

mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

http://www.wikidata.org/entity/Q35642870

about

Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases Time-Dependent Decay of mRNA and Ribosomal RNA during Platelet Aging and Its Correlation with Translation Activity Platelets in inflammation and atherogenesis Staphylococcus aureus α-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets Cationic PAMAM dendrimers disrupt key platelet functions.Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients.Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.Slowed decay of mRNAs enhances platelet specific translation Platelets and megakaryocytes contain functional nuclear factor-kappaB.Dissection of autophagy in human platelets.Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex.A tour through the transcriptional landscape of platelets.Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes.Protein synthesis by platelets: historical and new perspectives.Integrin αDβ2 (CD11d/CD18) is expressed by human circulating and tissue myeloid leukocytes and mediates inflammatory signaling.The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events.Leptin increases TNF-α expression and production through phospholipase D1 in Raw 264.7 cells.S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation.Translational control in endothelial cells.Regulation of the mTOR-Rac1 axis in platelet function Platelet mRNA: the meaning behind the message Platelets in lung biology.Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function.Platelets as cellular effectors of inflammation in vascular diseases.Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity.Amicus or adversary: platelets in lung biology, acute injury, and inflammation.PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids.Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop."Message in the platelet"--more than just vestigial mRNA!mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation.Platelets as central mediators of systemic inflammatory responses.Rho GTPases in platelet function Molecular biology of atherosclerosis.The platelet fibrinogen receptor: from megakaryocyte to the mortuary.Pneumococcal Adhesins PavB and PspC Are Important for the Interplay with Human Thrombospondin-1.RGDfK-functionalized gold nanorods bind only to activated platelets.Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin.NFkappaB regulation of platelet function: no nucleus, no genes, no problem?

P2860

Q26739670-1E8E534D-BB41-43E9-AE69-4F525FA10A0F Q27324375-D24006FC-500F-4E94-81D4-585A5B6D37CD Q28085020-08C48E94-C1DD-47D2-BA25-08A4CCA4BA8A Q30318276-C33BDFEE-40D8-4C67-B356-223B79AB1B25 Q30514562-DAF7827D-8F7F-4F63-A7B1-63038144229F Q33407003-6652E5A5-B7C2-45D7-AB75-FF2B61925884 Q33432917-D3616ECE-42AF-41FA-94F5-9CB46873B873 Q33615612-635B5C25-D373-492E-B2D9-71262D2993C5 Q33782701-D0AE5B6F-3C58-4604-A020-925A2D6DAE2F Q33878872-8BF28B02-319C-48A8-BEF2-409EBCC62F75 Q33897766-B9B31A58-0505-40F3-A951-9ECB0D6857B4 Q33948696-C43B055F-013D-4CA8-9019-601B944CE4A4 Q34173401-5B4D6612-9A5F-410C-B443-699612056E60 Q34522274-6C8ACBFA-361B-4EA4-8112-8397876CAE87 Q34557811-F328771A-1310-4BB9-ACFB-A985832174E4 Q34765561-88AAB5EC-BC5D-46E5-9E56-A7E8798C91AB Q35101184-26189C45-7966-4143-99FA-E5CCBE00CF17 Q35172479-375A33D8-444E-45D0-841A-21A2A4911C6A Q35210152-C865D3FE-2A91-490B-A9BB-6411E2D7BABA Q35220422-1FDDD7A0-49C2-4DEE-8F96-9B075C595BC8 Q35924824-224D201D-3649-47DA-869E-3D505BFE2545 Q36100859-650962F6-9B12-48B4-A78C-529492F2D198 Q36897250-7B6F96D6-DF1B-48B7-8445-D0F5DD6C76C5 Q36897267-0CEB6EC8-82CB-48E8-9E44-FECB764200D0 Q36996283-6D91285D-E7D8-4752-93FE-9D12E7B8C1E8 Q37081746-0CE1D4BD-4298-4A12-A2A0-7F52E9BC5324 Q37126477-169EDA2A-9346-4773-9B8E-7D7C9137E4EC Q37250787-B0A9635B-4C76-414D-9CF1-2FD6C43B4A4A Q37262394-458F62CA-F6CB-4069-8D6A-C36A71A03C75 Q37281999-96F78A44-CC3C-42D2-85C2-FE6FC5BBE46E Q37299929-525CA322-C1CB-4A38-9DB4-3D7E2CF99DE1 Q37396328-F01C8E54-7405-4077-895E-9C26FFA13D9A Q37809184-5C1E617B-3054-4418-BA32-99BFDB699022 Q38057431-F052DAFF-3547-4B5D-99B2-665A4A08E643 Q38125279-31B4B45A-C6FC-4DED-BA4F-33EA7A701881 Q38156780-A3411AF1-F6CE-4FBA-BB41-8AA01724D7C6 Q38884066-5BBCAD45-237B-47CD-B7C4-3A65F9BC7395 Q39371541-1B5B2602-0328-469B-A29B-DA36E816C7A8 Q40693554-C539F1AF-D5C4-4009-A3C5-FF06ACC8A6E0 Q41769481-4E44E131-4F16-4B05-B8E5-DC438F256F93

P2860

mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

http://www.wikidata.org/entity/Q35642870

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

mTOR-dependent synthesis of Bc ...... by activated human platelets.

@ast

mTOR-dependent synthesis of Bc ...... by activated human platelets.

@en

type

label

mTOR-dependent synthesis of Bc ...... by activated human platelets.

@ast

mTOR-dependent synthesis of Bc ...... by activated human platelets.

@en

prefLabel

mTOR-dependent synthesis of Bc ...... by activated human platelets.

@ast

mTOR-dependent synthesis of Bc ...... by activated human platelets.

@en

P1433

Q35642870-6A9C8987-C63F-4CB2-A3CB-BE0F622845FA

P1476

Q35642870-6F41443C-7692-4E01-A4B8-244F27B882E9

P2093

Q35642870-0CB7379A-3E6C-4342-9A21-A641E86EE422

Q35642870-12F92698-9E8D-406B-BCB9-CDEBCFD53573

Q35642870-788FC32B-1FA9-4F0B-A30C-DD1460E27D30

Q35642870-9D2C949B-CAAF-4106-9E03-3F536F03B436

Q35642870-9EE3421C-0A5D-411A-BFDB-2AEC9B670FA0

Q35642870-BE82770A-49CB-493C-853C-DF2C4FE5E206

Q35642870-E6479087-F4AA-428C-B7CF-67A947FB58A0

P2860

Q35642870-00131F79-B609-4367-A41E-834E09545F50

Q35642870-0314E4C7-FC6B-4E1E-B75D-C81AAFC3E442

Q35642870-034EDCB4-207D-4847-AD92-C2327E274ABD

Q35642870-13D43AF1-23DD-40C2-9E1A-8379ADC71078

Q35642870-1CF525D5-D468-4578-95EE-BA32E4A485EC

Q35642870-209E3CA0-8849-49F6-A6A8-4D7DC6351FD7

Q35642870-229E7719-6C05-437C-A5A7-7372739A3CFE

Q35642870-250B9731-612E-4261-A59F-1CE6456BCF3C

Q35642870-33A325A1-7B00-4943-A173-9AD8BA32159E

Q35642870-33A622EF-6271-4D8C-9C0B-454E0726A564

P304

Q35642870-4C50A565-7C46-41ED-8C61-08220446B82F

P31

Q35642870-F8C1C6BD-862E-4345-87AF-DF2FF164D336

P356

Q35642870-764CD550-2D6E-45A8-8559-EF7A58B3B451

P407

Q35642870-E5B265A4-B768-4435-B43D-E9AFE871F897

P433

Q35642870-58A33096-5087-47B0-AB77-8EE2B107E06B

P478

Q35642870-3533F62F-4267-4C52-8EB4-D15DA7AE74C3

P50

Q35642870-1AB1BCEF-CA65-4036-ABE5-A5FC56C78407

Q35642870-732C5634-E05C-4423-8B52-7135769FD9F6

Q35642870-EF9276D8-C254-4DC1-824F-2BB7C15051A1

P577

Q35642870-7B22B6C7-1656-4A77-A3F1-1AB8D1351FC8

P5875

Q35642870-33FF7716-B966-48AE-A5F7-BCF9B5AE2652

P698

Q35642870-F06B0E4F-9542-4698-9801-FAA36C44E80E

P932

Q35642870-F8446A1B-816B-4E1D-93CB-4AE6B3246191

P356

BLOOD-2006-08-042192

P1433

P1476

mTOR-dependent synthesis of Bc ...... s by activated human platelets

@en

P2093

Eliott Spencer

http://www.w3.org/2001/XMLSchema#string

Guy A Zimmerman

http://www.w3.org/2001/XMLSchema#string

Hansjorg Schwertz

http://www.w3.org/2001/XMLSchema#string

Larry W Kraiss

http://www.w3.org/2001/XMLSchema#string

Melvin M Denis

http://www.w3.org/2001/XMLSchema#string

Neal D Tolley

http://www.w3.org/2001/XMLSchema#string

Thomas M McIntyre

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

Regulation of Bcl-3 through interaction with the Lck tyrosine kinase

Platelet genomics and proteomics in human health and disease.

Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets

TOR signaling in growth and metabolism

Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins

Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates

Scientific and therapeutic advances in antiplatelet therapy

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events

P304

1975-1983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-08-042192

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Kurt H. Albertine

P577

2006-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6688334

http://www.w3.org/2001/XMLSchema#string

P698

17110454

http://www.w3.org/2001/XMLSchema#string

P932

1801071

http://www.w3.org/2001/XMLSchema#string